Cabot (NYSE:CBT) Issues FY 2027 Earnings Guidance

Cabot (NYSE:CBT) issued an update on its FY 2027 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 6.150-6.750 for the period, compared to the consensus EPS estimate of 7.030.

Cabot Stock Down 1.7%

Shares of Cabot stock opened at $73.15 on Tuesday. The business has a fifty day simple moving average of $77.79 and a 200 day simple moving average of $79.52. The stock has a market cap of $3.78 billion, a PE ratio of 20.55, a price-to-earnings-growth ratio of 8.68 and a beta of 0.83. The company has a quick ratio of 0.97, a current ratio of 1.47 and a debt-to-equity ratio of 0.48. Cabot has a 12 month low of $58.33 and a 12 month high of $94.53.

Cabot (NYSE:CBT) last issued its earnings results on Monday, November 2nd. The specialty chemicals company reported $1.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.55 by $0.06. The firm had revenue of $1.01 billion for the quarter, compared to analysts’ expectations of $927.29 million. Cabot had a return on equity of 20.29% and a net margin of 5.23%. The company’s revenue was up 12.2% compared to the same quarter last year. During the same quarter last year, the business earned $1.70 earnings per share. Research analysts predict that Cabot will post 6.35 EPS for the current year.

Analyst Upgrades and Downgrades

Several brokerages have commented on CBT. Wall Street Zen raised shares of Cabot from a “hold” rating to a “buy” rating in a research note on Sunday, October 11th. JPMorgan Chase & Co. lifted their price target on shares of Cabot from $70.00 to $78.00 and gave the stock an “underweight” rating in a research report on Friday, August 7th. Weiss Ratings reissued a “hold (c)” rating on shares of Cabot in a research report on Friday, August 21st. UBS Group decreased their price target on shares of Cabot from $92.00 to $86.00 and set a “neutral” rating for the company in a report on Monday, October 5th. Finally, Truist Financial set a $100.00 price objective on shares of Cabot in a research report on Wednesday, August 5th. Two investment analysts have rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Cabot has a consensus rating of “Hold” and a consensus price target of $87.80.

Insider Transactions at Cabot

In other Cabot news, CEO Sean Keohane sold 134,895 shares of Cabot stock in a transaction dated Friday, August 28th. The stock was sold at an average price of $85.00, for a total value of $11,466,075.00. Following the sale, the chief executive officer owned 404,134 shares of the company’s stock, valued at $34,351,390. This trade represents a 25.03% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. In the last three months, insiders sold 229,597 shares of company stock worth $19,646,746. 3.08% of the stock is currently owned by corporate insiders.

More Cabot News

Here are the key news stories impacting Cabot this week:

• Positive Sentiment: Cabot reported fourth-quarter adjusted EPS of $1.61, above the $1.55 consensus estimate, while revenue increased 12.2% year over year to $1.01 billion, exceeding expectations by roughly $82.7 million. Cabot Beats Q4 Earnings and Revenue Estimates
• Positive Sentiment: The company secured a $50 million U.S. Department of Energy grant to expand domestic production of advanced battery conductive additives in Louisiana and Texas. Battery Materials generated $43 million of fiscal-year EBITDA, supporting the long-term growth narrative. Cabot Fiscal 2026 Results
• Positive Sentiment: Fiscal 2026 operating cash flow of $421 million funded $207 million of capital investments, $97 million of dividends and $146 million of share repurchases, indicating solid cash generation and shareholder returns. Cabot Fiscal 2026 Results
• Neutral Sentiment: Reported fourth-quarter diluted EPS was $1.25, while adjusted EPS was $1.61 after certain items. Fiscal-year adjusted EPS totaled $6.42, compared with $7.25 a year earlier, highlighting the difference between headline earnings and underlying performance. Cabot Fourth-Quarter and Full-Year Results
• Negative Sentiment: Cabot guided to fiscal 2027 EPS of $6.15-$6.75, below the $7.03 analyst consensus. The outlook suggests investors may need to lower earnings expectations and reflects concern about weaker margins and a challenging macroeconomic environment.
• Negative Sentiment: Although quarterly adjusted EPS beat estimates, it declined from $1.70 in the prior-year quarter. The combination of lower year-over-year profitability and cautious guidance is outweighing the revenue beat. Cabot Falls Despite Beating Estimates on Weaker Margins

Cabot Company Profile

Cabot Corporation (NYSE: CBT) is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company develops and manufactures materials used to improve the performance, durability, conductivity, color and purity of products across a range of industries.

Cabot’s products include carbon black used in tires, rubber goods, coatings, plastics and printing inks; specialty carbons and conductive materials for batteries and other applications; and specialty compounds and masterbatches.